Paradoxical increase in lumen size during progression of coronary atherosclerosis: Observations from the REVERSAL trial

Atherosclerosis

Volumn 189, Issue 1, 2006, Pages 229-235

  Sipahi, Ilke ^a   Tuzcu, E Murat ^a   Schoenhagen, Paul ^a   Nicholls, Stephen J ^a   Chen, Michael S ^a   Crowe, Timothy ^a   Loyd, Aaron B ^a   Kapadia, Samir ^a   Nissen, Steven E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Atherosclerosis; Coronary artery disease; Intravascular ultrasound; Remodeling

Indexed keywords

ATORVASTATIN; PRAVASTATIN;

ADULT; ARTERY DIAMETER; ARTERY ENDOTHELIUM; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROGENESIS; ATHEROMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; COURSE EVALUATION; DISEASE COURSE; FEMALE; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MEDICAL ASSESSMENT; OBSERVATIONAL STUDY; PRIORITY JOURNAL; REMISSION;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEPTANOIC ACIDS; HUMANS; MALE; MIDDLE AGED; PRAVASTATIN; PYRROLES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 33748090313     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.12.006     Document Type: Article

References (28)

1. Sones Jr. F.M., and Shirey E.K. Cine coronary arteriography. Mod Concepts Cardiovasc Dis 31 (1962) 735-738
2. Brown G., Albers J.J., Fisher L.D., et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 323 (1990) 1289-1298
3. Kane J.P., Malloy M.J., Ports T.A., Phillips N.R., Diehl J.C., and Havel R.J. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA 264 (1990) 3007-3012
4. Blankenhorn D.H., Azen S.P., Kramsch D.M., et al. Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS). Ann Intern Med 119 (1993) 969-976
5. Nissen S.E., Tsunoda T., Tuzcu E.M., et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 290 (2003) 2292-2300
6. Nissen S.E., Tuzcu E.M., Schoenhagen P., et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 291 (2004) 1071-1080
7. Okazaki S., Yokoyama T., Miyauchi K., et al. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study. Circulation 110 (2004) 1061-1068
8. Nissen S.E., Tuzcu E.M., Libby P., et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA 292 (2004) 2217-2225
9. Glagov S., Weisenberg E., Zarins C.K., Stankunavicius R., and Kolettis G.J. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 316 (1987) 1371-1375
10. Clarkson T.B., Prichard R.W., Morgan T.M., Petrick G.S., and Klein K.P. Remodeling of coronary arteries in human and nonhuman primates. JAMA 271 (1994) 289-294
11. Losordo D.W., Rosenfield K., Kaufman J., Pieczek A., and Isner J.M. Focal compensatory enlargement of human arteries in response to progressive atherosclerosis. In vivo documentation using intravascular ultrasound. Circulation 89 (1994) 2570-2577
12. Nissen S.E., Tuzcu E.M., Schoenhagen P., et al. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med 352 (2005) 29-38
13. Tuzcu E.M., Hobbs R.E., Rincon G., et al. Occult and frequent transmission of atherosclerotic coronary disease with cardiac transplantation. Insights from intravascular ultrasound. Circulation 91 (1995) 1706-1713
14. Mintz G.S., Nissen S.E., Anderson W.D., et al. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition. Measurement and reporting of intravascular ultrasound studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 37 (2001) 1478-1492
15. Di Mario C., Gorge G., Peters R., et al. Clinical application and image interpretation in intracoronary ultrasound. Study Group on Intracoronary Imaging of the Working Group of Coronary Circulation and of the Subgroup on Intravascular Ultrasound of the Working Group of Echocardiography of the European Society of Cardiology. Eur Heart J 19 (1998) 207-229
16. Gibbons G.H., and Dzau V.J. The emerging concept of vascular remodeling. N Engl J Med 330 (1994) 1431-1438
17. Mintz G.S., Kent K.M., Pichard A.D., Satler L.F., Popma J.J., and Leon M.B. Contribution of inadequate arterial remodeling to the development of focal coronary artery stenoses. An intravascular ultrasound study. Circulation 95 (1997) 1791-1798
18. Schoenhagen P., Ziada K.M., Kapadia S.R., Crowe T.D., Nissen S.E., and Tuzcu E.M. Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: an intravascular ultrasound study. Circulation 101 (2000) 598-603
19. Pasterkamp G., Schoneveld A.H., Hijnen D.J., et al. Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery. Atherosclerosis 150 (2000) 245-253
20. Schoenhagen P., Vince D.G., Ziada K.M., et al. Relation of matrix-metalloproteinase 3 found in coronary lesion samples retrieved by directional coronary atherectomy to intravascular ultrasound observations on coronary remodeling. Am J Cardiol 89 (2002) 1354-1359
21. Lim T.T., Liang D.H., Botas J., Schroeder J.S., Oesterle S.N., and Yeung A.C. Role of compensatory enlargement and shrinkage in transplant coronary artery disease. Serial intravascular ultrasound study. Circulation 95 (1997) 855-859
22. Shiran A., Mintz G.S., Leiboff B., et al. Serial volumetric intravascular ultrasound assessment of arterial remodeling in left main coronary artery disease. Am J Cardiol 83 (1999) 1427-1432
23. Von Birgelen C., Hartmann M., Mintz G.S., et al. Spectrum of remodeling behavior observed with serial long-term (>/=12 months) follow-up intravascular ultrasound studies in left main coronary arteries. Am J Cardiol 93 (2004) 1107-1113
24. Schartl M., Bocksch W., and Fateh-Moghadam S. Effects of lipid-lowering therapy on coronary artery remodeling. Coron Artery Dis 15 (2004) 45-51
25. Schoenhagen P., Ziada K.M., Vince D.G., Nissen S.E., and Tuzcu E.M. Arterial remodeling and coronary artery disease: the concept of "dilated" versus "obstructive" coronary atherosclerosis. J Am Coll Cardiol 38 (2001) 297-306
26. Corti R., Fayad Z.A., Fuster V., et al. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation 104 (2001) 249-252
27. Corti R., Fuster V., Fayad Z.A., et al. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation 106 (2002) 2884-2887
28. Hamasaki S., Higano S.T., Suwaidi J.A., et al. Cholesterol-lowering treatment is associated with improvement in coronary vascular remodeling and endothelial function in patients with normal or mildly diseased coronary arteries. Arterioscler Thromb Vasc Biol 20 (2000) 737-743